DarioHealth Corp.(DRIO)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

DarioHealth Corp. (DRIO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores DRIO at 18.8/100 on a 32-signal composite quality model, placing it at rank #2,803 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (3.5) and profitability (5.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), DarioHealth Corp. reports quarterly revenue of $5.2M, net income of $-7.9M, free cash flow of $-6.1M. Top institutional holders of DRIO by reported 13-F value include Nantahala Capital Management, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. DRIO trades on the Nasdaq exchange and files with the SEC under CIK 1533998. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DRIO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DarioHealth Corp. directly from SEC EDGAR.